Brief: PYC Therapeutics Logs FY Prelim Income From Ordinary Activities A$26.17 Mln
28/08/2025 12:13
Aug 28 (Reuters) - PYC Therapeutics Ltd PYC.AX: FY PRELIM INCOME FROM ORDINARY ACTIVITIES A$26.17 MILLION PRELIM FY LOSS FROM ORDINARY ACTIVITIES AFTER TAX ATTRIBUTABLE A$50.3 MILLION Further company coverage: PYC.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsBrief: PYC Therapeutics Announces Grant Of Patents By The US Patent Office
Brief: PYC Therapeutics Appoints Chief Financial Officer
Australia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million